L. V. Kolobukhina

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

A. Gintsburg, D. Logunov, B. Naroditsky, 2017, Human vaccines & immunotherapeutics.

A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels

V. Gushchin, A. Gintsburg, D. Logunov, 2021, Frontiers in Immunology.

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants

A. Shchetinin, V. Gushchin, O. Voronina, 2021, Vaccines.

Virus-Vectored Ebola Vaccines

O. Voronina, A. Gintsburg, D. Logunov, 2017, Acta naturae.